(CCSI) Consensus Cloud Solutions - NASDAQ
Sector: Technology | Industry: Software - Infrastructure | Exchange: NASDAQ (USA) | Market Cap: 635m USD | Total Return: 60.8% in 12m
Avg Turnover: 5.20M
EPS Trend: 79.2%
Qual. Beats: 2
Rev. Trend: -85.1%
Qual. Beats: 1
Warnings
Choppy
Tailwinds
Idiosyncratic Leader, Confidence
Consensus Cloud Solutions, Inc. (CCSI) is a Software-as-a-Service (SaaS) provider specializing in digital cloud faxing and secure information delivery. Based in Los Angeles, the company operates a suite of interoperability tools designed to transform unstructured data into structured, actionable information, primarily for highly regulated sectors such as healthcare, government, and finance.
The company’s product portfolio includes eFax Corporate, jSign for digital signatures, and eFax Clarity, which utilizes natural language processing and artificial intelligence to enhance document workflows. In the healthcare sector, digital faxing remains a critical infrastructure component due to stringent HIPAA compliance requirements and the need for secure data exchange between disparate Electronic Health Record (EHR) systems.
The SaaS business model typically benefits from recurring revenue streams and high switching costs, particularly in industries where data security and regulatory alignment are mandatory. To better understand how these business fundamentals translate into market performance, consider reviewing the detailed metrics available on ValueRay. Consensus Cloud Solutions serves a global market, with active operations in the United States, Canada, and Ireland.
- Healthcare sector transition from legacy fax to digital interoperability platforms
- High interest rates increase debt service costs on long-term corporate bonds
- Retention rates among small business and individual eFax subscribers
- Growth in AI-driven clinical documentation and structured data extraction revenue
- Regulatory mandates for secure electronic health record exchange in public sectors
| Net Income: 88.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 2.83 > 1.0 |
| NWC/Revenue: 16.54% < 20% (prev 5.19%; Δ 11.35% < -1%) |
| CFO/TA 0.21 > 3% & CFO 142.6m > Net Income 88.1m |
| Net Debt (487.9m) to EBITDA (168.0m): 2.90 < 3 |
| Current Ratio: 1.80 > 1.5 & < 3 |
| Outstanding Shares: last quarter (19.0m) vs 12m ago -3.30% < -2% |
| Gross Margin: 80.22% > 18% (prev 79.76%; Δ 0.46% > 0.5%) |
| Asset Turnover: 53.66% > 50% (prev 55.49%; Δ -1.83% > 0%) |
| Interest Coverage Ratio: 4.36 > 6 (EBIT TTM 149.5m / Interest Expense TTM 34.3m) |
| A: 0.09 (Total Current Assets 130.2m - Total Current Liabilities 72.2m) / Total Assets 678.7m |
| B: 0.04 (Retained Earnings 25.5m / Total Assets 678.7m) |
| C: 0.23 (EBIT TTM 149.5m / Avg Total Assets 654.2m) |
| D: 0.03 (Book Value of Equity 22.0m / Total Liabilities 656.7m) |
| Altman-Z'' = 2.25 = BBB |
| DSRI: 0.91 (Receivables 24.4m/26.7m, Revenue 351.0m/349.4m) |
| GMI: 0.99 (GM 79.76% / 80.22%) |
| AQI: 0.92 (AQ_t 0.62 / AQ_t-1 0.68) |
| SGI: 1.00 (Revenue 351.0m / 349.4m) |
| TATA: -0.08 (NI 88.1m - CFO 142.6m) / TA 678.7m) |
| Beneish M = -3.16 (Cap -4..+1) = AA |
As of June 15, 2026, the stock is trading at USD 34.81 with a total of 112,588 shares traded.
Over the past week, the price has changed by +3.91%,
over one month by +21.84%,
over three months by +15.84% and
over the past year by +60.79%.
Consensus Cloud Solutions has received a consensus analysts rating of 3.83. Therefore, it is recommended to buy CCSI.
- StrongBuy: 4
- Buy: 0
- Hold: 0
- Sell: 1
- StrongSell: 1
| Analysts Target Price | 38 | 9.2% |
P/E Trailing = 7.5328
P/E Forward = 5.8548
P/S = 1.8082
P/B = 28.6425
Revenue TTM = 351.0m USD
EBIT TTM = 149.5m USD
EBITDA TTM = 168.0m USD
Long Term Debt = 549.8m USD (from longTermDebt, last quarter)
Short Term Debt = 9.57m USD (from shortTermDebt, last quarter)
Debt = 580.2m USD (from shortLongTermDebtTotal, last quarter) + Leases 11.7m
Net Debt = 487.9m USD (calculated: Debt 580.2m - CCE 92.3m)
Enterprise Value = 1.12b USD (634.7m + Debt 580.2m - CCE 92.3m)
Interest Coverage Ratio = 4.36 (Ebit TTM 149.5m / Interest Expense TTM 34.3m)
EV/FCF = 10.00x (Enterprise Value 1.12b / FCF TTM 112.2m)
FCF Yield = 10.00% (FCF TTM 112.2m / Enterprise Value 1.12b)
FCF Margin = 31.97% (FCF TTM 112.2m / Revenue TTM 351.0m)
Net Margin = 25.09% (Net Income TTM 88.1m / Revenue TTM 351.0m)
Gross Margin = 80.22% ((Revenue TTM 351.0m - Cost of Revenue TTM 69.4m) / Revenue TTM)
Gross Margin QoQ = 80.90% (prev 80.03%)
Tobins Q-Ratio = 1.65 (Enterprise Value 1.12b / Total Assets 678.7m)
Interest Expense / Debt = 5.91% (Interest Expense 34.3m / Debt 580.2m)
Taxrate = 25.49% (30.1m / 118.2m)
NOPAT = 111.4m (EBIT 149.5m * (1 - 25.49%))
Current Ratio = 1.80 (Total Current Assets 130.2m / Total Current Liabilities 72.2m)
Debt / Equity = 26.37 (Debt 580.2m / totalStockholderEquity, last quarter 22.0m)
Debt / EBITDA = 2.90 (Net Debt 487.9m / EBITDA 168.0m)
Debt / FCF = 4.35 (Net Debt 487.9m / FCF TTM 112.2m)
Total Stockholder Equity = 1.67m (last 4 quarters mean from totalStockholderEquity)
RoA = 13.46% (Net Income 88.1m / Total Assets 678.7m)
RoE = 5.29k% (out of range, set to none) (Net Income TTM 88.1m / Total Stockholder Equity 1.67m)
RoCE = 27.12% (EBIT 149.5m / Capital Employed (Equity 1.67m + L.T.Debt 549.8m))
RoIC = 18.61% (NOPAT 111.4m / Invested Capital 598.6m)
WACC = 7.52% (E(634.7m)/V(1.21b) * Re(10.37%) + D(580.2m)/V(1.21b) * Rd(5.91%) * (1-Tc(0.25)))
Discount Rate = 10.37% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 11.11 | Cagr: -0.40%
[DCF] Terminal Value 77.97% ; FCFF base≈101.9m ; Y1≈116.8m ; Y5≈171.8m
[DCF] Fair Price = 114.0 (EV 2.59b - Net Debt 487.9m = Equity 2.10b / Shares 18.4m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 79.22 | EPS CAGR: 3.83% | SUE: 1.55 | # QB: 2
Revenue Correlation: -85.13 | Revenue CAGR: -1.36% | SUE: 1.23 | # QB: 1
EPS current Quarter (2026-06-30): EPS=1.48 | Chg30d=+2.48% | Revisions=+43% | Analysts=4
EPS next Quarter (2026-09-30): EPS=1.48 | Chg30d=+2.74% | Revisions=+43% | Analysts=4
EPS current Year (2026-12-31): EPS=5.86 | Chg30d=+3.25% | Revisions=+33% | GrowthEPS=+4.2% | GrowthRev=+2.2%
EPS next Year (2027-12-31): EPS=6.03 | Chg30d=+2.30% | Revisions=+43% | GrowthEPS=+3.0% | GrowthRev=+3.4%
[Analyst] Revisions Ratio: +43%